Physician profile
Efrain Paz
NPI 1750326534
$1,716.94
in general payments reported to CMS, 2019-2025
8 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $77.04 · 2021: $52.21 · 2022: $401 · 2023: $330 · 2024: $305 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $883.04 | 2019-2025 | Mako, Trident, Insignia |
| Zimmer Biomet Holdings, INC. | $357.18 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $173.98 | 2019-2025 | Peak, Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $128.43 | 2019-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $81.36 | 2022-2025 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $63.84 | 2020-2023 | Renasys Go V2 Home, Pico 7 |
| Kowa Pharmaceuticals America, INC. | $17.00 | 2023 | Seglentis |
| Pacira Therapeutics, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efrain Paz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.